a Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada
b Behavioral Research Unit, Alberta Childrens Hospital, Calgary, Alberta, Canada
c Pediatric Psychology
d Clinical Health Psychology, University of Tilburg, Tilburg, Netherlands
OBJECTIVE. We sought to examine the neurobehavioral profile of neonates who are born to women with hypothyroxinemia during early pregnancy.
METHODS. Examined were 108 neonates who were born to mothers with low maternal free thyroid hormone (fT4 concentrations; <10th percentile) at 12 weeks gestation (case patients) and 96 neonates who were born to women whose fT4 values were between the 50th and 90th percentiles, matched for parity and gravidity (control subjects). Newborn development was assessed at 3 weeks of age using the Neonatal Behavioral Assessment Scale. Maternal thyroid function (fT4 and thyrotropin hormone) was assessed at 12, 24, and 32 weeks gestation.
RESULTS. Infants of women with hypothyroxinemia at 12 weeks gestation had significantly lower scores on the Neonatal Behavioral Assessment Scale orientation index compared with subjects. Regression analysis showed that first-trimester maternal fT4 but not maternal TSH or fT4 later in gestation was a significant predictor of orientation scores.
CONCLUSIONS. This study confirms that maternal hypothyroxinemia constitutes a serious risk factor for neurodevelopmental difficulties that can be identified in neonates as young as 3 weeks of age.
Key Words: neonatal outcome thyroid disorders
Abbreviations: fT4free thyroid hormone TSHthyrotropin hormone NBASNeonatal Behavioral Assessment Scale TPO-Abthyroid peroxidase antibodies EPDSEdinburgh Postnatal Depression Scale RDCResearch Diagnostic Criteria STAIState-Trait Anxiety Inventory ANOVAanalysis of variance ADHDattention-deficit/hyperactivity disorder
This article has been cited by other articles:
![]() |
M. Moleti, V. P. Lo Presti, M. C. Campolo, F. Mattina, M. Galletti, M. Mandolfino, M. A. Violi, G. Giorgianni, D. De Domenico, F. Trimarchi, et al. Iodine Prophylaxis Using Iodized Salt and Risk of Maternal Thyroid Failure in Conditions of Mild Iodine Deficiency J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2616 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al. Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care Diabetes Care, May 1, 2008; 31(5): 1060 - 1079. [Full Text] [PDF] |
||||
![]() |
B. M. Casey, J. S. Dashe, C. Y. Spong, D. D. McIntire, K. J. Leveno, and G. F. Cunningham Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy Obstet. Gynecol., May 1, 2007; 109(5): 1129 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
Hypothyroidism in the pregnant woman DTB, July 1, 2006; 44(7): 53 - 56. [Abstract] [Full Text] [PDF] |
||||